About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 438 record(s)
Req # A-2021-002092
The Screening acceptance letter(s) sent by Health Canada to any and all generic drug manufacturer(s) regarding any and all Abbreviated New Drug Submissions for the following medicinal ingredients or combinations of medicinal ingredients: Amphotericin B, Buffer solution-melphalan hydrochloride, Lidocaine-prilocaine, Rocuronium bromide, Cabazitaxel, fesoterodine fumarate which were been added to the list of Generic Submissions Under Review dated March 15, 2022.Organization: Health Canada
July 2022
Req # A-2022-000058
The product licence for H.F.B. with the Natural Product Number (NPN) 80046717.Organization: Health Canada
July 2022
Req # A-2022-000067
A list of the grants and other payments made by Health Canada to Physicians for A Smoke Free Canada from January 1, 2012 to December 31, 2021. Include the amount paid and when they were paid. A list of the documents or services or other work products Health Canada has received in exchange for these grants and other payments for the same time period (January 1, 2012 to December 31, 2021).Organization: Health Canada
July 2022
Req # A-2022-000068
All briefing materials prepared and/or provided to the Minister of Health and/or the Minister of Mental Health and Addictions and Associate Minister of Health and/or the Deputy Minister of Health and/or their staffs related to the Low-Risk Drinking Guidelines and the Canadian Centre on Substance Use and Addiction. Period of October 31, 2021 to April 14, 2022.Organization: Health Canada
July 2022
Req # A-2022-000079
The strength(s) of any and all generic drugs which are listed on the list of Generic Submissions Under Review as of April 19, 2022 for the following medicinal ingredient: Tiotropium bromide monohydrate.Organization: Health Canada
July 2022
Req # A-2022-000154
Footnote #36 of the Draft Evaluation of the Health Portfolio Tobacco and Vaping Activities 2016-17 to 2020-21, made available through ATI A 2021-00914 makes reference to the following document: "Health Portfolio Tobacco and Vaping Activities : Performance Measurement Strategy". A copy of this document/report.Organization: Health Canada
July 2022
Req # A-2022-000155
Footnote #37 of the Evaluation of the Health Portfolio Tobacco and Vaping Activities 2016-17 to 2020-21, made public on Health Canada's website on April 26, 2022 makes reference to the following document: "Health Canada (2017). Technical Reference Sheet Harm Reduction & Cessation". A copy of this document/report.Organization: Health Canada
July 2022
Req # A-2022-000226
Number of valid registration certificates for the cultivation of medical cannabis for personal use or by a designated person, as well as the daily quantity authorized for each certificate, by sector of the province of Ontario as of April 2022.Organization: Health Canada
July 2022
Req # A-2022-000355
Communications between Health Canada and Prime Minister Justin Trudeau's office regarding Prime Minister Justin Trudeau's travel to the United States (US) - Colorado Springs - on June 7, 2022. Documents verifying use of Arrivecan app by Prime Minister Justin Trudeau prior to both his departure to Colorado Springs on June 7, 2022, and re-entrance to Canada on June 11, 2022.Organization: Health Canada
July 2022
Req # A-2022-000356
All assessments of Research Ethics Boards conducted from January 1, 2004 to December 31, 2008 by Health Canada. All records created or generated as part of the assessment process.Organization: Health Canada
July 2022